Table 3 Epidemiology and antibiotic resistance rates amongst the predominant BHS groups
Characteristic | Category | GAS | GBS | GGS | Total | p value |
|---|---|---|---|---|---|---|
Sex, n (%) | Female | 47 (88.7) | 2 (3.8) | 4 (7.5) | 53 (100.0) | 0.03 |
Male | 37 (78.7) | 9 (19.2) | 1 (2.1) | 47 (100.0) | ||
Total | 84 (84.0) | 11 (11.0) | 5 (5.0) | 100 (100.0) | ||
Age, n (%) | ≤3 month | 4 (80.0) | 1 (20.0) | 0 (0.00) | 5 (100.0) | 0.03 |
3 month to ≤5 years | 26 (100) | 0 (0.0) | 0 (0.0) | 26 (100.0) | ||
5 to ≤15 years | 12 (100.0) | 0 (0.0) | 0 (0.0) | 12 (100.0) | ||
15–35 years | 11 (68.8) | 3 (18.8) | 2 (12.5) | 16 (100.0) | ||
>35 years | 9 (69.2) | 3 (23.08) | 1 (7.69) | 13 (100.0) | ||
Othersa | 12 (70.6) | 3 (17.7) | 2 (11.8) | 17 (100.0) | ||
Total | 74 (83.2) | 10 (11.2) | 5 (5.6) | 89 (100.0) | ||
Penicillin resistance, n (%) | Resistant | 5 (71.4) | 2 (28.6) | 0 (0.0) | 7 (100.0) | 0.3 |
Sensitive | 121 (78.57) | 17 (11.0) | 16 (10.4) | 154 (100.0) | ||
Total | 126 (78.3) | 19 (11.8) | 16 (9.9) | 161 (100.0) | ||
Clindamycin resistance, n (%) | Intermediate | 1 (100.0) | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0.04 |
Resistant | 2 (33.3) | 3 (50.0) | 1 (16.7) | 6 (100.0) | ||
Sensitive | 123 (79.9) | 16 (10.4) | 15 (9.7) | 154 (100.0) | ||
Total | 126 (78.3) | 19 (11.8) | 16 (9.9) | 161 (100.0) | ||
Erythromycin resistance, n (%) | Intermediate | 6 (66.7) | 2 (22.2) | 1 (1.1) | 9 (100.0) | 0.4 |
Resistance | 8 (66.7) | 2 (16.7) | 2 (16.7 | 12 (100.0) | ||
Sensitive | 112 (80.0) | 15 (10.7) | 13 (9.3) | 140 (100.0) | ||
Total | 126 (78.3) | 19 (11.8) | 16 (9.9) | 161 (100.0) |